Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients.

[1]  R. Campos,et al.  Hereditary angioedema: quality of life in Brazilian patients , 2013, Clinics.

[2]  T. Machnig,et al.  C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life. , 2012, Allergy and asthma proceedings.

[3]  M. Triggiani,et al.  Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group , 2012, Allergy.

[4]  M. Cicardi,et al.  Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21‐month prospective study in a cohort of 103 patients , 2011, Allergy.

[5]  W. Lumry,et al.  The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. , 2010, Allergy and asthma proceedings.

[6]  B. Morgan.  Hereditary angioedema--therapies old and new. , 2010, The New England journal of medicine.

[7]  P. Keith,et al.  2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[8]  A. Kaplan,et al.  The bradykinin-forming cascade and its role in hereditary angioedema. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[9]  A. Bygum,et al.  Hereditary angio‐oedema in Denmark: a nationwide survey , 2009, The British journal of dermatology.

[10]  T. Craig,et al.  Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. , 2009, Allergy and asthma proceedings.

[11]  K. Andersen,et al.  Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. , 2009, European journal of dermatology : EJD.

[12]  R. Peebles,et al.  The spectrum and treatment of angioedema. , 2008, The American journal of medicine.

[13]  K. Bork,et al.  Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[14]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[15]  F. Rosen,et al.  Deficiencies of C1 inhibitor. , 2005, Best practice & research. Clinical gastroenterology.

[16]  M. López-Trascasa,et al.  Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[17]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[18]  H. Farkas,et al.  Sex hormones in hereditary angioneurotic oedema , 2004, Clinical endocrinology.

[19]  A. Stray-Pedersen,et al.  Primary Immunodeficiency Diseases in Norway , 2000, Journal of Clinical Immunology.

[20]  K. Bork,et al.  Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. , 2003, Archives of internal medicine.

[21]  K. Bork,et al.  Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. , 2003, The American journal of medicine.

[22]  B. Zuraw,et al.  Detection of C1 inhibitor mutations in patients with hereditary angioedema. , 2000, The Journal of allergy and clinical immunology.

[23]  T. Perneger,et al.  The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. , 1998, Journal of clinical epidemiology.

[24]  M. Cicardi,et al.  Plasma bradykinin in angio-oedema , 1998, The Lancet.

[25]  M. Borum,et al.  Hereditary angioedema. Complex symptoms can make diagnosis difficult. , 1998, Postgraduate medicine.

[26]  T. Fest,et al.  [Hereditary angioneurotic edema: an underestimated medical emergency. Apropos of 33 cases]. , 1995, Annales de dermatologie et de venereologie.

[27]  M. Cicardi,et al.  Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.

[28]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[29]  G. Lagrue,et al.  [Hereditary angioneurotic edema. Recent progress in diagnosis and treatment. Importance of a national registry]. , 1991, Allergie et immunologie.

[30]  A. Sheffer,et al.  Tranexamic acid therapy in hereditary angioneurotic edema. , 1972, The New England journal of medicine.

[31]  G. Lagrue,et al.  [Angioneurotic edema of the hereditary type with abnormal serum complement (O.A.N.H.)]. , 1970, La Presse medicale.

[32]  W. Osler.  HEREDITARY ANGIO‐NEUROTIC ŒDEMA , 1888 .